UBS Group
EXCU

UBS Group’s Exelon Corporation EXCU Stock Holding History

UBS Group’s Portfolio EXCU Stock Details EXCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,139
Closed -$56K – 8347
2017
Q1 		$56K Buy
1,139
+291
+34% +$14.3K ﹤0.01% 5447
2016
Q4 		$41K Sell
848
-1,792
-68% -$83.8K ﹤0.01% 5989
2016
Q3 		$124K Sell
2,640
-44
-2% -$2.15K ﹤0.01% 4871
2016
Q2 		$132K Buy
2,684
+1,769
+193% +$84.9K ﹤0.01% 4847
2016
Q1 		$45K Buy
915
+240
+36% +$10.7K ﹤0.01% 5592
2015
Q4 		$27K Sell
675
-50
-7% -$2.08K ﹤0.01% 6446
2015
Q3 		$32K Hold
725
– – ﹤0.01% 6239
2015
Q2 		$33K Buy
725
+36
+5% +$1.75K ﹤0.01% 6407
2015
Q1 		$34K Buy
689
+254
+58% +$13K ﹤0.01% 6438
2014
Q4 		$23K Buy
+435
New +$22.9K ﹤0.01% 7479

UBS Group's EXCU Position: Q2 2017 in Review

UBS Group sold out of Exelon Corporation (EXCU) in Q2 2017, closing a stake of 1,139 shares — an estimated $56K sold.

UBS Group first reported a position in EXCU in Q4 2014 and held it in 10 quarters. The position peaked at $132K in Q2 2016. 0 funds tracked by Wall St. Rank hold EXCU as of Q2 2017.

  • UBS Group reported no remaining Exelon Corporation position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 1,139 Exelon Corporation shares in Q2 2017, an estimated $56K.
  • UBS Group first reported a position in Exelon Corporation in Q4 2014 and held it in 10 quarters.
  • UBS Group's Exelon Corporation position peaked at $132K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Exelon Corporation as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.